US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 2.630
  • +0.020+0.77%
Close Apr 26 16:00 ET
  • 2.640
  • +0.010+0.38%
Post 19:34 ET
80.42MMarket Cap-427P/E (TTM)

BioXcel Therapeutics Key Stats

BioXcel Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 9, 2024

Revenue(YoY)

632.60K

+207.09%
EPS(YoY)

-0.75

+59.31%

Buy

Apr 15, 2024

BioXcel Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 708.600K--
May 9, 20242024/Q1-- / 632.600K--
Mar 12, 20242023/Q4376.000K / 741.290K--
Nov 14, 20232023/Q3341.000K / 626.000K--
Aug 14, 20232023/Q2457.000K / 466.880K--
May 8, 20232023/Q1206.000K / 323.750K--
Mar 9, 20232022/Q4238.000K / 1.078M--
Nov 10, 20222022/Q3137.000K / 1.005M--
Aug 9, 20222022/Q20.000 / 0.000--
May 9, 20222022/Q10.000 / 125.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 708.600K--
May 9, 20242024/Q1-- / 632.600K--
Mar 12, 20242023/Q4376.000K / 741.290K--
Nov 14, 20232023/Q3341.000K / 626.000K--
Aug 14, 20232023/Q2457.000K / 466.880K--
May 8, 20232023/Q1206.000K / 323.750K--
Mar 9, 20232022/Q4238.000K / 1.078M--
Nov 10, 20222022/Q3137.000K / 1.005M--
Aug 9, 20222022/Q20.000 / 0.000--
May 9, 20222022/Q10.000 / 125.000K--

Unlock Free Earnings Estimates

BioXcel Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 15, 2024

Buy

  • Buy

    60.00%
  • Hold

    40.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg